96 related articles for article (PubMed ID: 35451196)
1. CD164 identifies CD4
Benoit BM; Jariwala N; O'Connor G; Oetjen LK; Whelan TM; Werth A; Troxel AB; Sicard H; Zhu L; Miller C; Takeshita J; McVicar DW; Kim BS; Rook AH; Wysocka M
Arch Dermatol Res; 2017 Jan; 309(1):11-19. PubMed ID: 27766406
[TBL] [Abstract][Full Text] [Related]
2. Clinical Outcomes of COVID-19 in Mycosis Fungoides and Sezary Syndrome.
Levy Yurkovski I; Rokach L; Melamed G; Alapi H; Gazit S; Patalon T; Tadmor T
Acta Haematol; 2023; 146(6):496-503. PubMed ID: 37517402
[TBL] [Abstract][Full Text] [Related]
3. The biomarker landscape in mycosis fungoides and Sézary syndrome.
Dulmage B; Geskin L; Guitart J; Akilov OE
Exp Dermatol; 2017 Aug; 26(8):668-676. PubMed ID: 27897325
[TBL] [Abstract][Full Text] [Related]
4. Computational Flow Cytometry Accurately Identifies Sezary Cells Based on Simplified Aberrancy and Clonality Features.
Seheult JN; Weybright MJ; Jevremovic D; Shi M; Olteanu H; Horna P
J Invest Dermatol; 2024 Jan; ():. PubMed ID: 38237727
[TBL] [Abstract][Full Text] [Related]
5. Itchy Skin: A Challenging Differential Diagnosis Between Mycosis Fungoides and Sézary Syndrome.
Abreu Rocha C; Drummond Borges M; Santos GM; Sousa M; Teixeira T
Cureus; 2023 Oct; 15(10):e46427. PubMed ID: 37927614
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with the silicon phthalocyanine pc 4 induces apoptosis in mycosis fungoides and sezary syndrome.
Lam M; Lee Y; Deng M; Hsia AH; Morrissey KA; Yan C; Azzizudin K; Oleinick NL; McCormick TS; Cooper KD; Baron ED
Adv Hematol; 2010; 2010():896161. PubMed ID: 21197103
[TBL] [Abstract][Full Text] [Related]
7. PD-1 Overexpression in Sézary Syndrome Is Epigenetically Regulated.
Najidh S; Zoutman WH; Schrader AMR; Willemze R; Tensen CP; Vermeer MH
J Invest Dermatol; 2023 Dec; 143(12):2538-2541.e7. PubMed ID: 37270066
[No Abstract] [Full Text] [Related]
8. The Interferon story continues: EORTC CLTG Study Explores Pegylated Interferon Alpha-2α's Role in Treating Mycosis Fungoides/Sézary Syndrome.
Stadler R
Br J Dermatol; 2024 May; ():. PubMed ID: 38703059
[No Abstract] [Full Text] [Related]
9. Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry.
Wadsworth P; Zhang J; Miller T; Menke J; Oak J; Fernandez-Pol S
Leuk Lymphoma; 2024 May; ():1-4. PubMed ID: 38747176
[No Abstract] [Full Text] [Related]
10. Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group.
Porwit A; Béné MC; Duetz C; Matarraz S; Oelschlaegel U; Westers TM; Wagner-Ballon O; Kordasti S; Valent P; Preijers F; Alhan C; Bellos F; Bettelheim P; Burbury K; Chapuis N; Cremers E; Della Porta MG; Dunlop A; Eidenschink-Brodersen L; Font P; Fontenay M; Hobo W; Ireland R; Johansson U; Loken MR; Ogata K; Orfao A; Psarra K; Saft L; Subira D; Te Marvelde J; Wells DA; van der Velden VHJ; Kern W; van de Loosdrecht AA
Cytometry B Clin Cytom; 2023 Jan; 104(1):27-50. PubMed ID: 36537621
[TBL] [Abstract][Full Text] [Related]
11. Differential diagnosis and identification of prognostic markers for peripheral T-cell lymphoma subtypes based on flow cytometry immunophenotype profiles.
Pu Q; Qiao J; Liu Y; Cao X; Tan R; Yan D; Wang X; Li J; Yue B
Front Immunol; 2022; 13():1008695. PubMed ID: 36466894
[TBL] [Abstract][Full Text] [Related]
12. Folliculotropic Mycosis Fungoides Is Associated with Decreased PD1 Staining Compared with Classic Mycosis Fungoides.
Tang H; Rybski KJ; Luan Y; Smoller BR
Dermatopathology (Basel); 2023 Oct; 10(4):303-309. PubMed ID: 37873805
[TBL] [Abstract][Full Text] [Related]
13. 19-color, 21-Antigen Single Tube for Efficient Evaluation of B- and T-cell Neoplasms.
Chan A; Gao Q; Roshal M
Curr Protoc; 2023 Sep; 3(9):e884. PubMed ID: 37725693
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the Mechanisms of PD-1 Regulation in Sézary Syndrome: Epigenetic Regulation as Potential Mechanism?
Querfeld C
J Invest Dermatol; 2023 Dec; 143(12):2338-2339. PubMed ID: 37610396
[No Abstract] [Full Text] [Related]
15. PD-1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome.
Lewis NE; Gao Q; Petrova-Drus K; Pulitzer M; Sigler A; Baik J; Moskowitz AJ; Horwitz SM; Dogan A; Roshal M
Cytometry B Clin Cytom; 2022 May; 102(3):189-198. PubMed ID: 35451196
[TBL] [Abstract][Full Text] [Related]
16. Determination of immunophenotypic aberrancies provides better assessment of peripheral blood involvement by mycosis fungoides/Sézary syndrome than quantification of CD26- or CD7- CD4+ T-cells.
Lyapichev KA; Bah I; Huen A; Duvic M; Routbort MJ; Wang W; Jorgensen JL; Medeiros LJ; Vega F; Craig FE; Wang SA
Cytometry B Clin Cytom; 2021 Mar; 100(2):183-191. PubMed ID: 32667737
[TBL] [Abstract][Full Text] [Related]
17. The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells.
Bernengo MG; Novelli M; Quaglino P; Lisa F; De Matteis A; Savoia P; Cappello N; Fierro MT
Br J Dermatol; 2001 Jan; 144(1):125-35. PubMed ID: 11167693
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric detection of peripheral blood involvement by mycosis fungoides and Sézary syndrome using T-cell receptor Vbeta chain antibodies and its application in blood staging.
Feng B; Jorgensen JL; Jones D; Chen SS; Hu Y; Medeiros LJ; Wang SA
Mod Pathol; 2010 Feb; 23(2):284-95. PubMed ID: 19935642
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
